Showing 1 - 8 results of 8 for search 'Mari K Halle', query time: 0.03s Refine Results
  1. 1
    Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent diseaseResearch in context

    Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent diseaseResearch in context by Hilde E. Lien, Hege F. Berg, Mari K. Halle, Jone Trovik, Ingfrid S. Haldorsen, Lars A. Akslen, Camilla Krakstad

    Published 2023-06-01
    Get full text
    Article
  2. 2
    Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595]

    Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 10459... by Hilde E. Lien, Hege F. Berg, Mari K. Halle, Jone Trovik, Ingfrid S. Haldorsen, Lars A. Akslen, Camilla Krakstad

    Published 2023-12-01
    Get full text
    Article
  3. 3
    Impact of MRI radiomic feature normalization for prognostic modelling in uterine endometrial and cervical cancers

    Impact of MRI radiomic feature normalization for prognostic modelling in uterine endometrial and cervical cancers by Erlend Hodneland, Erling Andersen, Kari S. Wagner-Larsen, Julie A. Dybvik, Njål Lura, Kristine E. Fasmer, Mari K. Halle, Camilla Krakstad, Ingfrid Haldorsen

    Published 2024-07-01
    Get full text
    Article
  4. 4
    APOBEC3A/B deletion polymorphism and endometrial cancer risk

    APOBEC3A/B deletion polymorphism and endometrial cancer risk by Nigar Sofiyeva, Camilla Krakstad, Mari K. Halle, Tracy A. O'Mara, Pål Romundstad, Kristian Hveem, Lars Vatten, Per E. Lønning, Liv B. Gansmo, Stian Knappskog

    Published 2023-03-01
    Get full text
    Article
  5. 5
    Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.

    Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer. by Henrica M J Werner, Jone Trovik, Mari K Halle, Elisabeth Wik, Lars A Akslen, Even Birkeland, Therese Bredholt, Ingvild L Tangen, Camilla Krakstad, Helga B Salvesen

    Published 2014-01-01
    Get full text
    Article
  6. 6
    MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer

    MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer by Kari S. Wagner‐Larsen, Erlend Hodneland, Kristine E. Fasmer, Njål Lura, Kathrine Woie, Bjørn I. Bertelsen, Øyvind Salvesen, Mari K. Halle, Noeska Smit, Camilla Krakstad, Ingfrid S. Haldorsen

    Published 2023-10-01
    Get full text
    Article
  7. 7
    Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer

    Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer by Njål Lura, Kari S. Wagner-Larsen, Stian Ryste, Kristine Fasmer, David Forsse, Jone Trovik, Mari K. Halle, Bjørn I. Bertelsen, Frank Riemer, Øyvind Salvesen, Kathrine Woie, Camilla Krakstad, Ingfrid S. Haldorsen

    Published 2025-02-01
    Get full text
    Article
  8. 8
    MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer

    MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer by Kari S. Wagner-Larsen, Njål Lura, Ankush Gulati, Stian Ryste, Erlend Hodneland, Kristine E. Fasmer, Kathrine Woie, Bjørn I. Bertelsen, Øyvind Salvesen, Mari K. Halle, Noeska Smit, Camilla Krakstad, Ingfrid S. Haldorsen

    Published 2025-01-01
    Get full text
    Article

Search Tools: